Montclair, NJ ― June 19, 2008 ― Jack Mycka, President and Partner of MME, LLC, will join with Manny Papadimitropoulos Ph.D. (Director, Health Outcomes Research, Intercontinental Region and Japan, Eli Lilly Canada Inc., and Assistant Professor, Faculty of Pharmacy, University of Toronto, Toronto, Canada) and Wayne Critchley (Partner and Leader, Drug Pricing and Reimbursement Team, Gowling Lafleur Henderson LLP, Ottawa, Canada) to offer a new course entitled Elements of Pharmaceutical/Biotech Pricing at ISPOR’s Third Asia-Pacific Conference to be held in Seoul, Korea, September 7-9.
This course is being offered at the Asia-Pacific meeting for the first time and will be targeted at the expected audience; it therefore contains different content from the two pricing courses offered at the ISPOR International and European meetings.
Elements of Pharmaceutical/Biotech Pricing is designed to give participants with limited experience in this area a basic understanding of the key terminology and issues involved in pharma/biotech pricing decisions within a global context. It will cover the tools to build and document product value including issues, information, and processes employed, as well as the role of pharmacoeconomics and the differences in payment systems that help to shape pricing decisions.
For more information on the conference, please visit the ISPOR Web site**.
For additional information about this course or Medical Marketing Economics, please contact us at 662.281.0502 or via e-mail at info@m2econ.com.
**Link will open in a new window
